← Back to Search

Organ Preservation Device

Kidney perfusion pump for Kidney Transplant (SNOPO Trial)

N/A
Waitlist Available
Led By Patrick Luke, MD
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year from start of study
Awards & highlights
No Placebo-Only Group

Summary

Kidney transplantation remains the best treatment option for patients with end-stage kidney failure, however, the need for transplantable organs far exceeds the number of acceptable grafts available from deceased donors. In an effort to increase access to transplantation, organs from higher risk donors are being used more frequently. Patients who receive these high risk kidneys are more likely to experience poor outcomes post-transplantation, such as delayed graft function and shorter graft survival than those who receive standard criteria donor kidneys. One way to improve outcomes in these high risk kidneys is to limit the amount of damage donor organs sustain during the transplant process. The current standard of care is storage of the donor organ on ice until the time of transplant, during which the kidney incurs injury from cold and lack of oxygen. Recent research suggests that oxygenated machine perfusion of the organ at room temperature as a storage method can help protect kidneys and improve post-transplant outcomes. This study aims to assess the feasibility and safety of room temperature oxygenated machine perfusion of donor kidneys prior to transplantation. Kidney function will be evaluated with standard clinical parameters and participants will be followed for one-year post-transplantation for their outcomes. Feasibility will be evaluated in terms of trial process such as recruitment rate and ease of implementation of the study intervention. Preliminary safety will be assessed by incidence of graft discard and technical limitations.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year from start of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year from start of study for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Eligible versus actual kidney perfusions performed to assess study feasibility
Rate of kidney discard or graft failure attributed to the study intervention
Secondary study objectives
Degree of ischemia-reperfusion injury by kidney biopsy
Post-transplant serum creatinine levels to assess graft function
Rate of delayed graft function in study participants

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Subnormothermic PerfusionExperimental Treatment1 Intervention
Kidneys retrieved for transplantation will undergo subnormothermic oxygenated perfusion using the study device and perfusion solution for at least 1 hour prior to transplantation into the recipient.

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
677 Previous Clinical Trials
421,612 Total Patients Enrolled
Patrick Luke, MDPrincipal InvestigatorLawson Health Research Institute
~3 spots leftby Nov 2025